Logo

OHI

Omega Healthcare Investors, Inc.

OHI

Omega Healthcare Investors, Inc. NYSE
$45.92 0.22% (+0.10)

Market Cap $13.57 B
52w High $46.16
52w Low $35.04
Dividend Yield 2.68%
P/E 25.51
Volume 748.48K
Outstanding Shares 295.53M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $311.591M $101.984M $179.719M 57.678% $0.63 $331.578M
Q2-2025 $282.506M $99.576M $136.599M 48.353% $0.46 $280.6M
Q1-2025 $276.785M $117.024M $109.032M 39.392% $0.34 $246.748M
Q4-2024 $279.318M $100.455M $113.341M 40.578% $0.41 $252.5M
Q3-2024 $276.028M $89.942M $111.762M 40.489% $0.43 $243.286M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $737.186M $10.596B $5.352B $5.036B
Q2-2025 $734.184M $10.546B $5.357B $4.988B
Q1-2025 $367.957M $9.706B $4.774B $4.741B
Q4-2024 $518.34M $9.898B $5.167B $4.537B
Q3-2024 $342.444M $9.572B $5.172B $4.208B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $16.835M $226.714M $-83.799M $-139.05M $2.42M $239.482M
Q2-2025 $140.479M $239.265M $-463.547M $588.955M $368.512M $226.807M
Q1-2025 $95.847M $183.108M $18.105M $-347.698M $-144.663M $162.935M
Q4-2024 $113.341M $227.15M $-279.916M $243.409M $188.425M $211.671M
Q3-2024 $111.762M $186.47M $-133.458M $268.131M $321.179M $178.202M

Revenue by Products

Product Q2-2011Q3-2011Q4-2011Q1-2012
Issuer And Subsidiary Guarantors
Issuer And Subsidiary Guarantors
$60.00M $0 $0 $70.00M
Non Guarantor Subsidiaries
Non Guarantor Subsidiaries
$10.00M $0 $0 $10.00M
Sun Health Care Group Inc
Sun Health Care Group Inc
$0 $10.00M $10.00M $0
CommuniCare Health Services
CommuniCare Health Services
$0 $10.00M $0 $0

Five-Year Company Overview

Income Statement

Income Statement Revenue has been trending upward over the past few years after a soft patch, and profitability has generally improved as well. Operating profits have recovered nicely from earlier dips, suggesting better rent collections and fewer issues with troubled tenants. Earnings per share have been a bit bumpy year to year, reflecting the reality that senior care operators can face reimbursement and cost pressures, but overall profit levels are clearly positive and moving in the right direction. In short, the income statement shows a mature REIT with solid, though somewhat cyclical, earnings power rather than rapid growth or deep distress.


Balance Sheet

Balance Sheet The balance sheet looks relatively steady and typical for a large REIT. Total assets have inched up, indicating a slightly larger property base. Debt remains significant but has started to edge down, while equity has grown, which together point to a gradual strengthening of the capital structure. Cash on hand is meaningfully higher than a few years ago, giving Omega a bit more flexibility and a better liquidity cushion than when it was running with very little cash. Overall, leverage is still an important risk to watch, but the trend is toward a somewhat stronger, less stretched balance sheet.


Cash Flow

Cash Flow Cash generation from operations has been consistent and comfortably positive over the entire period shown. Because Omega’s model is not very capital‑intensive year to year, free cash flow closely tracks operating cash flow, meaning most of the cash coming in is available for debt service, dividends, and opportunistic investments rather than being tied up in heavy development spending. This stability is a key strength for a healthcare REIT, and it helps buffer the business against temporary earnings swings or tenant issues, as long as rent collections remain solid.


Competitive Edge

Competitive Edge Omega occupies a focused niche in skilled nursing and assisted living facilities, where scale and experience really matter. Its large, diversified portfolio and long-standing relationships with operators give it an edge in sourcing and underwriting deals. The triple‑net lease structure shifts many operating costs and responsibilities to tenants, helping Omega maintain more predictable income. At the same time, the company is heavily exposed to the health of a relatively narrow tenant base that depends on government and insurance reimbursements, so regulatory changes and operator financial strain remain key competitive and structural risks.


Innovation and R&D

Innovation and R&D Rather than building technology for itself, Omega acts as a technology enabler for its tenants. It backs tools like AI‑based fall detection, virtual reality for resident engagement, and a proprietary resident‑communication platform, aiming to make its facilities safer, more attractive, and more efficient for operators. This tenant‑centric approach is a differentiator versus more hands‑off landlords. Looking forward, continued tech partnerships and selective acquisitions are likely to be the main levers of innovation, with success depending on whether these tools actually improve clinical outcomes, occupancy, and operator profitability.


Summary

Omega Healthcare Investors appears to be a steady, income‑oriented healthcare REIT with improving fundamentals rather than a high‑growth story. Revenues and operating profits are trending upward, cash flows are stable, and the balance sheet is slowly strengthening, though leverage is still meaningful. Its competitive moat rests on specialization in senior care real estate, scale, triple‑net leases, and close operator relationships, balanced against exposure to reimbursement risk and tenant health. Strategic use of technology to support operators and favorable long‑term demographics in aging populations create interesting opportunities, but the business remains sensitive to policy changes, interest rates, and the financial condition of its care providers.